ClinicalTrials.Veeva

Menu

Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer (INFPELV)

C

Complejo Hospitalario Universitario Insular Materno Infantil

Status

Enrolling

Conditions

Ovarian Cancer (OvCa)
Ovarian Adenocarcinoma
Ovarian Cancer

Treatments

Other: resection of infundibulopelvic ligament

Study type

Observational

Funder types

Other

Identifiers

NCT07100288
2024-430-1

Details and patient eligibility

About

Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.

    • FIGO 2014 stage IA-IVB.
    • Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
    • Patients with no residual disease after surgery.
    • Patients with ECOG performance status 0-1.

Exclusion criteria

  • ◦ Patients without epithelial ovarian cancer.

    • Patients with ECOG 2-4.
    • Patients who do not consent to participate in the study.
    • Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.

Trial design

200 participants in 1 patient group

ovarian cancer patients
Treatment:
Other: resection of infundibulopelvic ligament

Trial contacts and locations

1

Loading...

Central trial contact

beatriz NAVARRO SANTANA, pHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems